
Se autoriza bamlanivimab para su uso de emergencia en COVID-19
noviembre 11, 2020 12:19 pmEl gobierno de Estados Unidos asignará 300.000 dosis de bamlanivimab a pacientes de alto riesgo, sin coste para ellos
El gobierno de Estados Unidos asignará 300.000 dosis de bamlanivimab a pacientes de alto riesgo, sin coste para ellos
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.